Abstract
Conclusion and SummaryThere was an apparent, brief prolongation of the mean skin homograft survival in 241 rats which were given 6-MP. However, neither long term administration nor high doses of this drug consistently prolonged survival time. A few of the treated animals in the higher dosage groups had unusually long graft survivals which accounted for the over-all increase of mean graft survival. Most of the animals in all groups sloughed off their grafts at or near the expected time.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
